As you may know, 23andMe collects and holds sensitive, immutable, identifiable personal information about millions of ...

Genetic testing company 23andMe has filed for bankruptcy after struggling with financial difficulties and strategic missteps. As the company prepares for a sale, concerns are growing over what will ...

Sen. Bill Cassidy is probing 23andMe, which recently filed for bankruptcy protection, to ensure the company does not sell ...

Over the weekend, biotechnology company 23andMe filed for Chapter 11 bankruptcy. Questions remain over what could happen to ...

23andMe might have filed for bankruptcy, but the transformation it brought to health care over nearly two decades is irreversible. I’m a physician, scientist, and advocate for public health.

Forbes contributors publish independent expert analyses and insights. I write about privacy including AI, privtech, data justice and law.

In a shocking development for investors and fans of genetic testing, 23andMe (ME) shares are plummeting, set to open around $1 this Monday morning after the company filed for Chapter 11 bankruptcy.

23andMe filed for Chapter 11 bankruptcy on Sunday. The company says no changes will be made to how it stores, manages or protects customer data up until the sale of its assets is finalized.